Skip To Main Content
Valeria Barcella on Muck Rack

Valeria Barcella

As seen in: Memory Studies
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Valeria

Contact Valeria, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Vaccinations in patients with multiple sclerosis: A Delphi consensus statement

|
By Valeria Barcella, Simone V. Benatti, Marco Capobianco, Agostino Riva
| Memory Studies
1. GBD 2016 Neurology Collaborators . Global, regional, and national burden of multiple sclerosis 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019; 18(3): 269–285. Google Scholar | Medline 2. Montalban, X, Gold, R, Thompson, AJ, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler 2018; 24(2): 96–120. Google Scholar | SAGE Journals | ISI 3. Harding, K, Williams, O, Willis, M, et al.
Open in Who Shared Issue with article?

The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement

|
By Lucia Moiola, Valeria Barcella, Simone V. Benatti, Marco Capobianco
| Memory Studies
1. Thompson, AJ, Baranzini, SE, Geurts, J, et al. Multiple sclerosis. Lancet 2018; 391(10130): 1622–1636. Google Scholar | Crossref | Medline 2. Epstein, DJ, Dunn, J, Deresinski, S. Infectious complications of multiple sclerosis therapies: Implications for screening, prophylaxis, and management. Open Forum Infect Dis 2018; 5(8): ofy174. Google Scholar | Crossref | Medline 3. Klotz, L, Havla, J, Schwab, N, et al. Risks and risk management in modern multiple sclerosis immunotherapeutic treatment.
Open in Who Shared Issue with article?
See all 2 articles